Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan Tablets, USP 80 mg Rx Only 50 Tablets (5x10) Unit Dose NDC 50268-784-15 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

D-1131-2018

August 14, 2018

Class II

Product summary

Firm
AVKARE Inc.
Event
Event 80828
Status
Terminated
Classification
Class II
Quantity
728 cartons (36,400 tablets)
Official record key
drug-enforcement:D-1131-2018

Official wording

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Code information: Lots: 18492 Exp. 11/2018; 20169 Exp. 05/2019

Distribution pattern: U.S. Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations